Cost-effectiveness analysis of switching from a bivalent to a nonavalent HPV vaccination programme in China: a modelling study
Bill & Melinda Gates Foundation (INV-031449 and INV-003174) and CAMS Innovation Fund for Medical Sciences (CIFMS) (2021-I2M-1-004).
Authors
- You‐Lin Qiao (ORCID: https://orcid.org/0000-0001-6380-0871)
- Meng Gao (ORCID: https://orcid.org/0000-0001-6941-0284)
- Xuelian Zhao (ORCID: https://orcid.org/0000-0003-3585-018X)
- Yang Liu (ORCID: https://orcid.org/0000-0002-9368-0425)
- Mark Jit (ORCID: https://orcid.org/0000-0001-6658-8255)
- Fanghui Zhao (ORCID: https://orcid.org/0000-0001-9294-0005)
- Yuting Hong
- Shangying Hu (ORCID: https://orcid.org/0000-0002-4778-1612)
- Chen Wang (ORCID: https://orcid.org/0000-0003-3995-4242)
- Tingting You (ORCID: https://orcid.org/0000-0002-0944-106X)
Institutions
- Capital Medical University (CN)
- Chinese Academy of Medical Sciences & Peking Union Medical College (CN)
- China-Japan Friendship Hospital (CN)
- London School of Hygiene & Tropical Medicine (GB)
- Beijing Institute of Neurosurgery (CN)
- University of Hong Kong (HK)
Publication Details
- Journal
- The Lancet Regional Health - Western Pacific
- Published
- 2025-02-20
- DOI
- https://doi.org/10.1016/j.lanwpc.2025.101499
- Citations
- 2
- Primary Topic
- Cervical Cancer and HPV Research
- Type
- article
- Field-Weighted Citation Impact
- 2.71
Funders
- Bill and Melinda Gates Foundation
- Chinese Academy of Medical Sciences Initiative for Innovative Medicine